Armata Pharmaceuticals ARMP
NYSE ARMP
$3.50 +0.20 (+6.06%)
At close: Oct 2, 2026 · 4:00 PM EDT

Armata Pharmaceuticals (ARMP) Selling, General & Administrative (2013 - 2026)

Updated

Armata Pharmaceuticals (ARMP) reported Selling, General & Administrative of $5.24 million for Q2 2026, up 99.9% from $2.62 million a year earlier and up 51.2% from the prior quarter.

Analysis

Armata Pharmaceuticals (ARMP) Selling, General & Administrative (2013 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Armata Pharmaceuticals' Selling, General & Administrative came in at $15.24 million, up 22.5% year-over-year; for FY2025, it came in at $12.41 million, down 5.9% from FY2024.

  • Selling, General & Administrative has a five-year compound annual growth rate of 9.3% (FY2020 to FY2025).
  • By year, Selling, General & Administrative came in at $13.18 million in FY2024 (+13.2%), $11.65 million in FY2023 (+56.6%), $7.44 million in FY2022 (-10.2%) and $8.28 million in FY2021 (+4.0%).
  • The Q2 2026 figure ranks as the highest quarterly Selling, General & Administrative in data going back to Q1 2013.
  • Year over year, Selling, General & Administrative has now increased in each of the last three quarters, with growth averaging 9.9% over the last eight quarters.
  • The high point for year-over-year Selling, General & Administrative in five years was Q3 2023 (growth of 129.5%); the low point was Q2 2025 (a decline of 23.8%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $3.46 million (Q1 2026), $3.43 million (Q4 2025) and $3.11 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 6.43 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 3.63 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -3.24 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn -5.65 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 1.92 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 3.41 Bn
10 Armata Pharmaceuticals 122.58 Mn 70.29 Mn - 5.24 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 5.24 Mn
Mar 31, 2026 3.46 Mn
Dec 31, 2025 3.43 Mn
Sep 30, 2025 3.11 Mn
Jun 30, 2025 2.62 Mn
Mar 31, 2025 3.25 Mn
Dec 31, 2024 3.32 Mn
Sep 30, 2024 3.24 Mn
Jun 30, 2024 3.44 Mn
Mar 31, 2024 3.18 Mn
Dec 31, 2023 3.18 Mn
Sep 30, 2023 3.58 Mn
Jun 30, 2023 2.35 Mn
Mar 31, 2023 2.54 Mn
Dec 31, 2022 1.81 Mn
Sep 30, 2022 1.56 Mn
Jun 30, 2022 2.08 Mn
Mar 31, 2022 1.98 Mn
Dec 31, 2021 2.22 Mn
Sep 30, 2021 1.77 Mn
API Access

Armata Pharmaceuticals Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=ARMP&period=max&api_key=YOUR_API_KEY